Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.3.1.900
Consolidated Balance Sheets - USD ($)
Dec. 31, 2015
Dec. 31, 2014
Current    
Cash and cash equivalents $ 6,617,082 $ 209,933
Prepaid expenses and other receivables (Note 3) 188,217 81,130
Due from related parties (Note 7) 38,554 44,986
Loans receivable (Note 4) 307,459 0
Total Current Assets 7,151,312 336,049
Equipment (Note 5) 87,103 77,922
Total Assets 7,238,415 413,971
Current    
Accounts payable (Note 7) 134,718 308,947
Accrued liabilities 57,840 155,463
Warrant derivative liability (Note 10) 6,067,869 0
Total Liabilities 6,260,427 464,410
Shareholders' Equity (Deficiency)    
Special Voting Preferred Stock, par value $0.001; Authorized - 1; Issued and outstanding - 1 (December 31, 2014 - Nil) 0 0
Common Shares, par value $0.001; Authorized - 150,000,000 (December 31, 2014 - 200,000,000); Exchangeable Shares; Authorized - Unlimited, Issued and outstanding - 22,428,313 and 50,000,000 Exchangeable Shares (December 31, 2014 - nil and 49,737,096 Exchangeable Shares) (Note 8) 72,428 49,737
Additional paid-in capital 11,412,399 4,936,456
Shares to be issued (Note 8(xiii)) 98,900 0
Deficit (10,647,888) (5,053,982)
Accumulated other comprehensive income 42,149 17,350
Total Shareholders' Equity (Deficiency) 977,988 (50,439)
Total Liabilities and Shareholders' Equity (Deficiency) $ 7,238,415 $ 413,971